A comparative study of Bhekarajarasadi Churna and Dhatri Loha on 80 patients of Iron deficiency anemia

An Open Randomised Comparative Clinical Study of Bhekarajarasadi Churna and Dhatri Loha in the Management of Pandu Roga Wsr to Iron Deficiency Anemia - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086665

Enrollment

Registered

2025-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age Patients aged 16 to 50 years Gender Both male and female will be included. Clinical Presentation Patients exhibiting signs and symptoms of Pandu Roga, including but not limited to Panduta pallor, Daurbalya weakness, Aruchi loss of appetite, Mandagni reduced digestive power, Shrama fatigue, and Shwasa shortness of breath. Haemoglobin Levels Men Haemoglobin levels between 8 and 12 gm per dL. Women Haemoglobin levels between 8 and 11 gm per dL. Informed Consent Patients must demonstrate an understanding of the study and be willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: Pregnant Women and Lactating Mothers Patients who are pregnant or breastfeeding. Infectious Diseases Patients currently suffering from active infectious diseases that may affect the study outcomes or interfere with treatment. Acute or Chronic Blood Loss Patients with conditions causing acute or chronic blood loss, such as gastrointestinal bleeding or heavy menstrual bleeding. Systemic Disorders Patients with systemic disorders or conditions e.g., severe cardiovascular, renal, or liver disease that could interfere with the studys course or affect the treatments efficacy and safety. Secondary, Congenital, and Hereditary Anemia Patients diagnosed with secondary anemia resulting from other underlying conditions, congenital anemia, or hereditary anemia such as thalassemia or sickle cell anemia. Lack of Consent Patients who are unwilling or unable to provide informed consent for participation in the study.

Design outcomes

Primary

Measure	Time frame
Panduta (Pallor) Pindiko Dweshtana (Leg Cramps) Gatrasada (Fatigue) Ayasena Shwasa (Dyspnoea) Hridayaspandana (Palpitation) Aalasya(Lethargy) Shiroruja (Headache) Gatrashoola (Bodyache) Bhrama (Giddiness) Dourbalya (Weakness) Hb level Iron Study TIBC Sr. Iron Sr. Ferritin Timepoint: Day 0 Day 15th Day 30th Day 45th	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactVidya Rao

APMS Ayurved Mahavidyalaya Sion

chaitalijadhav2015@gmail.com9284841625

Outcome results